May 15, 2008
| Bio-IT World > Sequence Gazing
Sequence Gazing


May 15, 2007 | The prodigious output from next-generation sequencing platforms offers exciting opportunities for sequence software specialists too. Tom Schwei, general manager of Madison, WI-based DNAStar, says that for almost 20 years, his company’s Lasergene software has “done a nice job of the ‘blocking and tackling’ of sequencing analysis” — sequence assembly, analysis, gene identification, and visualization. “We’ve been there, we’re still there, and we’re going to be there. It’s incredibly important to scientists using our product.”

Schwei says the most recent release of Lasergene had “a powered up assembly engine aimed at areas where next-generation sequencing is coming into play — taking Sanger data and complementing those with 454 data, and finding ways to do successful assemblies.”

While Lasergene is primarily a desktop tool useful for modestly sized genomes, DNAStar is developing a new genome assembler tool, currently in alpha testing with a couple of labs, including GATC Biotech in Germany (it recently purchased 454 and Solexa instruments.) “This could be powered up on a Linux cluster to handle larger organisms,” says Schwei. It takes better advantage of paired-end reads, using them for assembly, not just alignment. And “Because of the way the processing algorithm works, it processes several times faster than Lasergene. If you can use clusters, you will ultimately be able to do even greater than that.”

“Our philosophy is we want to be able to work with all the kinds of data out there. The closer our realationship to the manufacturers, the better. We’re not looking to replace the software they distribute... that’s not our goal. But we expect great value to end users as software that can handle 454, Solexa, Applied Bio, Helicos, and Sanger,” says Schwei.

“If one software package can take all those types of data and work well with those, that’s a tool that will be very valuable to many scientists.” -- K.D.

Return to main article.


Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

gq92112

This Bio•IT World Briefing On “Next-Generation Sequencing,”underwritten by GenomeQuest, Inc.,
presents a selection of feature stories, interviews,commentaries, conference reports, and editorials on the emergence, opportunities, and challenges posed by high-throughput sequencing. Covered in this collection: the launch of new
platforms from Applied Biosystems and Helicos; new applications of nextgen sequencing; the rise of personal genomics; and informatics solutions to vexing problem of managing the vast volumes of next-gen data.  Download now 



sgi_hybrid

SGI's Meeting Today’s Computational Needs for Science

The quest to better understand disease mechanisms and find new treatments is driven by new laboratory technologies and ever-more sophisticated modeling and simulation efforts. As such, life sciences R&D investigations increasingly are relying on more powerful computing resources. The challenge is how to accommodate the broad mix of applications.

Addressing this issue, this paper produced by the Bio-IT World Custom Publishing Group discusses a new SGI Hybrid Computing Environment approach. It optimally uses shared memory systems, multi-processor clusters, and FPGAs to accelerate computational workflows.



sgi_protm

SGI's Supercharging Proteomics Discovery

The deeper study of proteins and their interactions can reveal scientific information once considered nearly untouchable to scientists and researchers. Today, unprecedented advancements in computing power are enabling the creation of mounds of proteomic based data along with the accompanying bottlenecks data can create.

Rather than just “simplify the experiment” to fit the computational resources an alternative is now available with the SGI Proteomics Appliance. This complimentary white paper, produced by the Bio-IT World Custom Publishing Group, looks at ways to use the Proteomic Appliance to handle the most intensive proteomics computing tasks facing science today.



Life Science Webcasts & Podcasts

Waters

Automate Method SOPs for Greater Efficiency and Fewer Errors with Waters® NuGenesis® Intelligent Procedure Manager

waters podcastThe Waters® NuGenesis® SDMS Intelligent Procedure Manager is a workflow software package designed to guide the laboratory analyst through a routine, comprehensive method standard operating procedure (SOP) and integrate results with a chromatography data system. The Intelligent Procedure Manager addresses the predominately manual activities required to perform an analytical method or test, reducing cycle times up to 50-75% as compared to a traditional paper trail with fewer opportunities for human error.  From late-stage development to final product quality control and lot release, Intelligent Procedure Manager can be applied to any lab environment where rigorous adherence to approved test methods and SOPs must be followed, including compliance requirements for cGMP operations. Download Now


More Podcasts

Job Openings

Lilly Singapore Center for Drug Discovery (LSCDD) - Associate Director of Informatics
Lead and mentor a strong team for the Bioinformatics group at the Integrative Computational Sciences (ICS) department at LSCDD towards the development of novel algorithms, data analysis methods and software tools for drug discovery. Work closely with the Software Engineering group at ICS, and collaborate with the Discovery IT organization in Europe and USA. For additional information, or to apply visit: LSCDD 

 Lilly Singapore Center for Drug Discovery (LSCDD) - Senior Software Engineer
Join a strong team of software engineers in our Integrative Computational Sciences (ICS) at LSCDD. Collaborate with, and help develop integrated applications to process and visualize data from cutting-edge technologies used by scientists at Lilly Research Labs (LRL) and the Drug Discovery Research (DDR) teams. The Software Engineering team provides computational tools and tailored software solutions that enable the global effort of Tailored Therapeutics; ‘The Right Drug, at The Right Dose for The Right Patient at The Right Time'. For additional information, or to apply visit: LSCDD 

For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext 100 or via email to bio-itworld@theygsgroup.com.